Last week, medtech company Clinical Laserthermia Systems (CLS) published its report for the fourth quarter of 2020 and announced that it is conducting a rights issue and a directed share issue. Acting CEO Dan Mogren and CFO Lars-Erik Eriksson visited BioStock’s studio to tell us more about this and about CLS’ focus areas for 2021.
See the interview, in Swedish, with CLS acting CEO Dan Mogren and CFO Lars-Erik Eriksson below.
The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.